Gonadotrophin-releasing hormone analogues for pain associated with endometriosis (Q24235522)

https://api.crossref.org/works/10.1002%2F14651858.CD008475.PUB2

Metabolic changes during medical treatment of endometriosis: nafarelin acetate versus danazol

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008475.PUB2

THE MEDICAL TREATMENT OF MILD ENDOMETRIOSIS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008475.PUB2

Leuprolide in a 3-monthly versus a monthly depot formulation for the treatment of symptomatic endometriosis: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008475.PUB2

Equivalence of the 3-month and 28-day formulations of triptorelin with regard to achievement and maintenance of medical castration in women with endometriosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008475.PUB2

Depot goserelin and danazol pre-treatment before rollerball endometrial ablation for menorrhagia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008475.PUB2

New medical treatments for endometriosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008475.PUB2

Management of the pain associated with endometriosis: an update of the painful problems

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008475.PUB2

Subcutaneous goserelin versus intranasal buserelin for pituitary down-regulation in patients undergoing IVF: a randomized comparative study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008475.PUB2

Endometriosis: current therapies and new pharmacological developments.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008475.PUB2

Depressive symptoms associated with gonadotropin-releasing hormone agonists.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008475.PUB2

Experimental endometriosis: the nude mouse as a xenographic host

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008475.PUB2

Oral contraceptives for pain associated with endometriosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008475.PUB2

Laparoscopic surgery for pelvic pain associated with endometriosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008475.PUB2

ESHRE guideline for the diagnosis and treatment of endometriosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008475.PUB2

Endometriosis: the pathophysiology as an estrogen-dependent disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008475.PUB2

Progestagens and anti-progestagens for pain associated with endometriosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008475.PUB2

Endometriosis: cost estimates and methodological perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008475.PUB2

WITHDRAWN: Gonadotrophin-releasing hormone analogues for pain associated with endometriosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008475.PUB2

Leuprolide acetate for the treatment of endometriosis

21 January 2018

1 reference

12 December 2020

Nafarelin: a new medical therapy for endometriosis

1 reference

12 December 2020

[Treatment of pelvic endometriosis with goserelin acetate or nafarelin acetate. Comparative study]

1 reference

12 December 2020

Prolonged GnRH agonist and add-back therapy for symptomatic endometriosis: long-term follow-up

1 reference

12 December 2020

Short-term Lupron or danazol therapy for pelvic endometriosis

1 reference

12 December 2020

On the origin and significance of serum CA-125 concentrations in 97 patients with endometriosis before, during, and after buserelin acetate, nafarelin, or danazol

1 reference

12 December 2020

Memory complaints associated with the use of gonadotropin-releasing hormone agonists: a preliminary study.

1 reference

12 December 2020

Decrease in symptoms, blood loss and uterine size with nafarelin acetate before abdominal hysterectomy: a placebo-controlled, double-blind study.

1 reference

12 December 2020

An open randomized comparative study of the effect of goserelin depot and danazol in the treatment of endometriosis. Zoladex Endometriosis Study Team

1 reference

12 December 2020

A randomized comparison of danazol and leuprolide acetate suppression of serum-soluble CD23 levels in endometriosis

1 reference

12 December 2020

Effects of sodium etidronate in combination with low-dose norethindrone in patients administered a long-acting GnRH agonist: a preliminary report.

1 reference

12 December 2020

Zoladex (goserelin acetate implant) in the treatment of endometriosis: a randomized comparison with danazol. The Zoladex Endometriosis Study Group

1 reference

12 December 2020

Efficacy of intranasal or subcutaneous luteinizing hormone-releasing hormone agonist inhibition of ovarian function in the treatment of endometriosis

1 reference

12 December 2020

[Medical treatment of endometriosis: comparative study of leuprolide acetate and danazol]

1 reference

12 December 2020

A Comparative Treatment Trial of Endometriosis Using the Gonadotrophin-releasing Hormone Agonist, Nafarelin, and the Synthetic Steroid, Danazol

1 reference

12 December 2020

[Endometriosis: clinical, histological and morphometric findings before and after Gn-RH agonist therapy]

1 reference

12 December 2020

[Influence of GnRH analogue on the intensification of endometriosis symptoms and infertility treatment].

1 reference

12 December 2020

Effect of LH-RH agonist therapy in the treatment of endometriosis (German experience)

1 reference

12 December 2020

Treatment of endometriosis. Evaluation of preoperative therapy with danazol, gestrinone and buserelin (nasal spray and implant)

1 reference

12 December 2020

Treatment of endometriosis with the GnRH agonist nafarelin acetate

1 reference

12 December 2020

Administration of nasal Buserelin as compared with subcutaneous Buserelin implant for endometriosis

1 reference

12 December 2020

Nafarelin for endometriosis: a large-scale, danazol-controlled trial of efficacy and safety, with 1-year follow-up. The Nafarelin European Endometriosis Trial Group (NEET)

1 reference

12 December 2020

A comparison of the efficacy and safety of buserelin vs danazol in the treatment of endometriosis. Protocol 310 Study Group

1 reference

12 December 2020

Buserelin acetate in the treatment of pelvic pain associated with minimal and mild endometriosis: a controlled study

1 reference

12 December 2020

Comparison of the effects of leuprorelin acetate and danazol treatments on serum CA-125 levels in women with endometriosis

1 reference

12 December 2020

A randomized comparative study of the effect of leuprorelin acetate depot and danazol in the treatment of endometriosis.

1 reference

12 December 2020

Nafarelin vs. leuprolide acetate depot for endometriosis. Changes in bone mineral density and vasomotor symptoms. Nafarelin Study Group

1 reference

12 December 2020

[Treatment of endometriosis]

1 reference

12 December 2020

CA 125 levels in endometriosis patients before, during and after treatment with danazol or LHRH agonists

1 reference

12 December 2020

Evaluation of preoperative use of danazol, gestrinone, lynestrenol, buserelin spray and buserelin implant, in the treatment of endometriosis associated infertility

1 reference

12 December 2020

Effects of triptorelin versus placebo on the symptoms of endometriosis

1 reference

12 December 2020

[Goserelin depot: an analog of LHRH for the treatment of endometriosis]

1 reference

12 December 2020

Reversible pituitary ovarian suppression induced by an LHRH agonist in the treatment of endometriosis--comparison of two dose regimens

1 reference

12 December 2020

A double-blind randomized study of the treatment of endometriosis with nafarelin or nafarelin plus norethisterone

1 reference

12 December 2020

The effect of LHRH agonist therapy in the treatment of endometriosis (Dutch experience)

1 reference

12 December 2020

Effectiveness of tibolone on hypoestrogenic symptoms induced by goserelin treatment in patients with endometriosis

1 reference

12 December 2020

Efficacy and safety of nafarelin in the treatment of endometriosis

1 reference

12 December 2020

Danazol but not gonadotropin-releasing hormone agonists suppresses autoantibodies in endometriosis

1 reference

12 December 2020

Comparison of the gonadotropin-releasing hormone agonist goserelin acetate alone versus goserelin combined with estrogen-progestogen add-back therapy in the treatment of endometriosis

1 reference

12 December 2020

[Randomized, blind, parallel-controlled and multiple-centre clinical trial on the effectiveness and safety of leuprolide acetate in the treatment of endometriosis]

1 reference

12 December 2020

The levonorgestrel-releasing intrauterine system and endometriosis staging.

1 reference

12 December 2020

Gonadotrophin-releasing hormone analogues for endometriosis: bone mineral density

1 reference

12 December 2020

Human issues and medical economics of endometriosis. Three- vs. six-month GnRH-agonist therapy

1 reference

12 December 2020

Nafarelin in the management of endometriosis: quality of life assessment

1 reference

12 December 2020

Bone loss during gonadotropin releasing hormone agonist treatment and use of nasal calcitonin

1 reference

12 December 2020

Quantification of endometriosis-associated pain and quality of life during the stimulatory phase of gonadotropin-releasing hormone agonist therapy: a double-blind, randomized, placebo-controlled trial

1 reference

12 December 2020

Leuprorelin implant (ALZA). DUROS, leuprolide acetate implant, leuprolide implant, Viadur

1 reference

12 December 2020

Leuprorelin acetate depot vs danazol in the treatment of endometriosis: results of an open multicentre trial

1 reference

12 December 2020

Treatment of endometriosis with a decreasing dosage of a gonadotropin-releasing hormone agonist (nafarelin): a pilot study with low-dose agonist therapy ("draw-back" therapy)

1 reference

12 December 2020

The levonorgestrel-releasing intrauterine device reduces CA-125 serum levels in patients with endometriosis.

1 reference

12 December 2020

Chronic pelvic pain: prevalence, health-related quality of life, and economic correlates.

1 reference

12 December 2020

Randomized clinical trial of a levonorgestrel-releasing intrauterine system and a depot GnRH analogue for the treatment of chronic pelvic pain in women with endometriosis

1 reference

12 December 2020

Estrogenic suppression by different administration schedules of goserelin depot for treatment of endometriosis

1 reference

12 December 2020

A randomized, prospective comparison of endocrine changes induced with intranasal leuprolide or danazol for treatment of endometriosis

1 reference

12 December 2020

LH-RH agonist treatment of endometriosis

1 reference

12 December 2020

Clinical experience treating endometriosis with nafarelin.

1 reference

12 December 2020

Clinical study on finding optimal dose of a potent LHRH agonist (buserelin) for the treatment of endometriosis--multicenter trial in Japan.

1 reference

12 December 2020

Buserelin versus danazol in the treatment of endometriosis-associated infertility

1 reference

12 December 2020

Comparison between the effects of nafarelin and danazol on serum lipids and lipoproteins in patients with endometriosis

1 reference

12 December 2020

Goserelin depot versus danazol in the treatment of endometriosis the Australian/New Zealand experience

1 reference

12 December 2020

Nafarelin versus danazol in the treatment of endometriosis

1 reference

12 December 2020

Pain of endometriosis: effects of nafarelin and danazol therapy.

1 reference

12 December 2020

Role of nafarelin in the management of endometriosis

1 reference

12 December 2020

Administration of nasal nafarelin as compared with oral danazol for endometriosis. A multicenter double-blind comparative clinical trial

1 reference

12 December 2020

Effects of nafarelin versus danazol on lipids and calcium metabolism

1 reference

12 December 2020

A comparison of nafarelin acetate and danazol in the treatment of endometriosis

1 reference

12 December 2020

Prospective randomized double-blind trial of 3 versus 6 months of nafarelin therapy for endometriosis associated pelvic pain

1 reference

12 December 2020

Pre- and postoperative therapy with GnRH agonist for endometrial resection. A prospective, randomized study

1 reference

12 December 2020

A randomized, comparative trial of triptorelin depot (D-Trp6-LHRH) and danazol in the treatment of endometriosis

1 reference

12 December 2020

Ovarian suppression induced with Buserelin or danazol in the management of endometriosis: a randomized, comparative study

1 reference

12 December 2020

Depot leuprolide acetate versus danazol in the treatment of women with symptomatic endometriosis: a multicenter, double-blind randomized clinical trial. II. Assessment of safety. The Lupron Endometriosis Study Group

1 reference

12 December 2020

Depot leuprorelin acetate versus danazol in the treatment of infertile women with symptomatic endometriosis

1 reference

12 December 2020

Very low dose danazol for relief of endometriosis-associated pelvic pain: a pilot study.

1 reference

12 December 2020

The medical treatment of mild endometriosis

1 reference

12 December 2020

Vaginal patterns during danazol and buserelin acetate therapy for endometriosis: structural and ultrastructural study

1 reference

12 December 2020

A preliminary report on the comparative use of buserelin (Hoe 766) and danazol in the treatment of endometriosis: the University of Southern California experience

1 reference

12 December 2020

Buserelin acetate implants in the treatment of pain in endometriosis.

1 reference

12 December 2020

Serum-soluble CD23 in patients with endometriosis and the effect of treatment with danazol and leuprolide acetate depot injection

1 reference

12 December 2020

A randomized, parallel, comparative study of the efficacy and safety of nafarelin versus danazol in the treatment of endometriosis in Taiwan

1 reference

12 December 2020

The effect of LHRH agonist therapy in the treatment of endometriosis (English experience)

1 reference

12 December 2020

Medical therapy of endometriosis

1 reference

12 December 2020

Prolonged gonadotropin-releasing hormone agonist treatment of symptomatic endometriosis: the role of cyclic sodium etidronate and low-dose norethindrone "add-back" therapy.

1 reference

12 December 2020

Nafarelin in the treatment of pelvic pain caused by endometriosis

1 reference

12 December 2020

Endometriosis and pelvic pain

1 reference

12 December 2020

Depot leuprolide versus danazol in treatment of women with symptomatic endometriosis. I. Efficacy results

1 reference

12 December 2020

Goserelin versus danazol in the treatment of endometriosis

1 reference

12 December 2020

Lupron depot (leuprolide acetate for depot suspension) in the treatment of endometriosis: a randomized, placebo-controlled, double-blind study. Lupron Study Group

1 reference

12 December 2020

Randomized controlled trial of depot leuprolide in patients with chronic pelvic pain and clinically suspected endometriosis. Pelvic Pain Study Group.

1 reference

12 December 2020